Tintore, M., Rovira, A., Arrambide, G., Mitjana, R., Río, J., Auger, C., Nos, C., Edo, M.C., Castilló, J., Horga, A., Perez-Miralles, F., Huerga, E., Comabella, M., Sastre-Garriga, J. and Montalban, X. (2010) Brainstem Lesions in Clinically Isolated Syndromes. Neurology, 75, 1933-1938.
https://doi.org/10.1212/WNL.0b013e3181feb26f

has been cited by the following article:

• TITLE: Serum Level of Vitamin C in a Sample of Egyptian Patients with Multiple Sclerosis

  AUTHORS: Asmaa Ibrahim, Taha K. Alloush, Yousry Abo Elnaga, Mohamed Hamdy, Mohamed M. Fouad

  KEYWORDS: Vitamin C, Multiple Sclerosis

  JOURNAL NAME: Neuroscience and Medicine, Vol.10 No.4, December 27, 2019

  ABSTRACT: Background: Antioxidants such as vitamin C can eliminate free radicles responsible for oxidative stress. Objective: To assess the serum level of vitamin C in a sample of multiple sclerosis (MS) patients to investigate a possible role of vitamin C in the pathogenesis of MS. Subjects and Methods: Forty patients with MS and twenty healthy controls were included in this study. Vitamin C level was estimated for each participant. Results: Serum vitamin C levels were significantly lower among the patients (ranging from 0.28 mg/dL to 0.75 mg/dL with mean 0.47 ± 0.14 mg/dL and median of 0.46 mg/dL) compared to controls (ranging from 0.60 mg/dL to 2.90 mg/dL with mean 1.87 ± 0.61 mg/dL and median of 1.90 mg/dL) (P Conclusion: Patients with MS tended to have low serum vitamin C levels, and younger patients had lower serum levels.